| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/08/2009 | US20090011006 Once daily formulations of tetracyclines |
| 01/08/2009 | US20090010986 Polymeric gel delivery system for pharmaceuticals |
| 01/08/2009 | US20090010942 Novel primate chitinases and uses therefor |
| 01/08/2009 | US20090010930 Antibodies to vla-1 |
| 01/08/2009 | US20090010925 Antibody variants |
| 01/08/2009 | US20090010912 Use of Alkaline Phosphatase for the Detoxification of Lps Present at Mucosal Barriers |
| 01/08/2009 | US20090010879 Receptor Based Antagonists and Methods of Making and Using |
| 01/08/2009 | DE102005054700B4 Neue duale Peptidase-Inhibitoren als Prodrugs zur Therapie von entzündlichen und anderen Erkrankungen New dual peptidase inhibitors as prodrugs for the treatment of inflammatory and other diseases |
| 01/08/2009 | CA2693182A1 Compounds useful as raf kinase inhibitors |
| 01/08/2009 | CA2691107A1 Pharmaceutical combination of nsaid and prostaglandin compound |
| 01/08/2009 | CA2691102A1 Pharmaceutical combination of opioid and prostaglandin compound |
| 01/08/2009 | CA2689116A1 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof |
| 01/07/2009 | EP2011877A2 Conjugates for the modulation of immune responses |
| 01/07/2009 | EP2011870A1 Mutant polypeptide having effector function |
| 01/07/2009 | EP2011800A2 Inhibitors of caspase |
| 01/07/2009 | EP2011502A1 Silicon containing compounds and their use as anti-inflammatory agents |
| 01/07/2009 | EP2011499A2 Pyrrolo[2,3d]Pyrimidine compositions and their use |
| 01/07/2009 | EP2010501A2 Imidazole-based compounds, compositions comprising them and methods of their use |
| 01/07/2009 | EP2010486A2 Diazeniumdiolated non-steroidal anti-inflammatory drugs, compositions thereof, and related methods |
| 01/07/2009 | EP1896031B1 Thiazolopyrimidines for use in therapy |
| 01/07/2009 | EP1431285B1 Reverse hydroxamic acid derivatives |
| 01/07/2009 | EP1425277B1 Urea-compounds active as vanilloid receptor antagonists for the treatment of pain |
| 01/07/2009 | EP1341521B1 Nanoparticulate compositions comprising a drug and copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers |
| 01/07/2009 | EP1204665B1 Chemokine receptor antagonists and methods of use therefor |
| 01/07/2009 | EP0759985B1 Transgenic arthritic mice |
| 01/07/2009 | CN201175155Y Traditional Chinese medicine health-care bed cushion |
| 01/07/2009 | CN101341147A Substituted heterocyclic compounds with cxcr3 antagonist activity |
| 01/07/2009 | CN101341143A Inhibitors of CCR9 activity |
| 01/07/2009 | CN101341137A Pyrazine derivatives as epithelial sodium channel blocker |
| 01/07/2009 | CN101341134A 嘧啶衍生物 Pyrimidine derivatives |
| 01/07/2009 | CN101341123A 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| 01/07/2009 | CN101340894A Bursting pellets |
| 01/07/2009 | CN101337933A Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| 01/07/2009 | CN101337932A Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| 01/07/2009 | CN101337931A Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| 01/07/2009 | CN101337871A Indandione compound |
| 01/07/2009 | CN101337109A Vehicle-mounted multifunctional physiotherapy equipment |
| 01/07/2009 | CN101337072A Preparation method of sustained and controlled release medicine material |
| 01/07/2009 | CN101337061A Blood circulation promoting pain preventing plaster |
| 01/07/2009 | CN101337049A Production method of pills for treating rheumatoid, rheumatism and infantile paralysis |
| 01/07/2009 | CN101337039A Compound ilexlutifolia thumb preparation for treating acute tonsil inflammation |
| 01/07/2009 | CN101337031A Baicao pill |
| 01/07/2009 | CN101337030A Medicine composition for reducing swelling and easing pain, preparation method and use thereof |
| 01/07/2009 | CN101337024A Temperature lowering bladder normalizing decoction |
| 01/07/2009 | CN101337021A Shuanghulian thermo-toxin eliminating granule |
| 01/07/2009 | CN101337019A Oral traditional Chinese medicine formulation for treating herpes zoster post herpetic neuralgia and preparation method thereof |
| 01/07/2009 | CN101337012A External traditional Chinese medicine formulation for treating herpes zoster post herpetic neuralgia and preparation method thereof |
| 01/07/2009 | CN101337002A Traditional Chinese medicine capsule for treating rheumatism and nervous system |
| 01/07/2009 | CN101336995A Plaster for treating lumbar intervertebral disc protrusion |
| 01/07/2009 | CN101336993A External tincture for treating wind-dampness arthralgia and urgent sprain and preparation method thereof |
| 01/07/2009 | CN101336988A External medicine for treating qi stagnation and preparation method thereof |
| 01/07/2009 | CN101336985A Analgesic antipruritic medicinal wine and preparation method thereof |
| 01/07/2009 | CN101336972A Qingpeng paste and quality standard and detection method thereof |
| 01/07/2009 | CN101336960A Defervescence paste |
| 01/07/2009 | CN101336954A Medicine composition for treating cold and preparation method thereof |
| 01/07/2009 | CN101336953A Production method of traditional Chinese medicine for treating soft-tissue swell |
| 01/07/2009 | CN101336937A Honey antibiotics-removing technique and device |
| 01/07/2009 | CN101336703A Blood-stasis cooling decoction |
| 01/07/2009 | CN101336671A Low-fat freezing beverage and preparation method thereof |
| 01/07/2009 | CN100448875C Substituted 1-piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 01/07/2009 | CN100448469C Medicament for treating acute soft tissue injury and its preparation process |
| 01/07/2009 | CN100448452C Remedies |
| 01/07/2009 | CN100448451C Nutritional compositions with contain slightly negatively charged, non-digestible polysaccharides and use thereof for reducing transport through tight junctions |
| 01/07/2009 | CN100448446C Buckthorn extract, its preparing method and use in pharmaceutical process |
| 01/07/2009 | CN100448441C Compsn. for treatment of burns |
| 01/07/2009 | CN100448431C Oral disintegrated Anfenmame tablet for treating children's cold and its prepn |
| 01/06/2009 | US7473779 e.g. 2-amino-N-(4-{[amino(2-thienyl)methylidene]amino}phenethyl)-5-methoxybenzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent |
| 01/06/2009 | US7473761 Therapy for metabolic disorders; polycystic kidney diseasel diarrhea; gastrointestinal disorders |
| 01/06/2009 | US7473703 e.g. N-(4-{1-Hydroxy-1-[1-(2-methoxyethyl)-1H-pyrrol-2-yl]-ethyl}-phenyl)-N-methyl-benzenesulfonamide; liver X receptor (LXR) agonist; antidiabetic, antiproliferative agent; lipid, metabolic disorders, obesity, diabetes, hypercholesterolemia, atherosclerosis, hyperlipoproteinemia |
| 01/06/2009 | CA2494321C 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 01/06/2009 | CA2478374C N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/06/2009 | CA2421267C Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof |
| 01/06/2009 | CA2414095C Novel compounds |
| 01/06/2009 | CA2412541C 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-.beta.-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 01/06/2009 | CA2387058C Injection vehicle for polymer-based formulations |
| 01/06/2009 | CA2379086C 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 01/06/2009 | CA2369504C Pyrazole compositions useful as inhibitors of erk |
| 01/06/2009 | CA2348084C Crystallisation using supercritical or subcritical fluids |
| 01/06/2009 | CA2216546C 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2-one derivatives having pde iv and cytokine inhibiting activity |
| 01/01/2009 | US20090005580 Compounds, compositions and methods |
| 01/01/2009 | US20090005457 Solid forms comprising (-)-O-desmethylvenlafaxine and uses thereof |
| 01/01/2009 | US20090005426 Pharmaceutically active sulfonyl hydrazide derivatives |
| 01/01/2009 | US20090005420 Inhibitors of Matrix Metallaproteinases |
| 01/01/2009 | US20090005412 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 01/01/2009 | US20090005408 Process for the production of an abuse-proofed dosage form |
| 01/01/2009 | US20090005401 Novel Compounds |
| 01/01/2009 | US20090005381 Methods of treating serotonin-mediated diseases and disorders |
| 01/01/2009 | US20090005372 Cyclopropanecarboxylic acid {4-[3-(4-methoxy-phenyl)-[1,2,4]triazolo[3,4-a]phthalazin-6-ylamino]-phenyl}-amide; phosphodiesterase inhibitors; neoangiogenesis or inflammatory disease |
| 01/01/2009 | US20090005358 Compositions and methods for treating medical conditions |
| 01/01/2009 | US20090005353 used in treating and/or preventing cardiovascular disorders, inflammatory diseases, Alzheimer's disease, dyslipidemia and metabolic syndrome |
| 01/01/2009 | US20090005351 Hormone replacement therapy |
| 01/01/2009 | US20090005347 Via bisphosphonate drug; for prophylaxis of cartilage destruction or chondrolysis associated with osteonecrosis and/or osteochondritis dissecans |
| 01/01/2009 | US20090005344 Blocking inflammatory cytokines; tumor necrosis factor; phosphodieaterase inhibitor; antiarthritic agents; psoriasis; inflammatory bowel disorders; chronic obstructive pulmonary disorders |
| 01/01/2009 | US20090005338 Carbonyl-substituted titanocenes |
| 01/01/2009 | US20090005334 Nucleic acid derivatives |
| 01/01/2009 | US20090005331 AChE antisense oligonucleotide as an anti-inflammatory agent |
| 01/01/2009 | US20090005330 Methods and Compositions to Inhibit P2x7 Receptor Expression |
| 01/01/2009 | US20090005322 Physiologically- Active Composition Based on Collagen |
| 01/01/2009 | US20090004295 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 01/01/2009 | US20090004264 Methods for treating and ameliorating the symptons of inflammatory bowel diseases |